Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Graves' Orbitopathy
NCT01379196Phase 2Withdrawn
- Sponsor
- Rabin Medical Center
- Start
- May 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of azithromycin in Graves' ophthalmopathy (TED), sponsored by Rabin Medical Center. Planned start May 2011; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NCT01379196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379196.